drugset / Trial / NCT07817108
Phase III Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above
Phase 3
Recruiting
18000 enrolled
Suzhou Abogen Biosciences Co., Ltd.
Abogen Biosciences (Shanghai) Co., Ltd · collab
RandomizedParallel-groupTriple-blindPrevention
Summary
The primary objective of this study is to evaluate the vaccine efficacy, safety and immunogenicity of 2 injections (approximately 2 months apart) of ABO1108 in adults aged 40 years or above.
Timeline
- Start
- 2026-06-27
- Primary completion
- 2027-10-17
- Completion
- 2027-10-17
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABO1108 | Messenger RNA (mRNA) | — | — |